Cite
HARVARD Citation
von Tresckow, B. et al. (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leukemia & lymphoma. 60 (11), pp. 2705-2711. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
von Tresckow, B. et al. (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leukemia & lymphoma. 60 (11), pp. 2705-2711. [Online].